6F3X

Backbone structure of Des-Arg10-Kallidin (DAKD) peptide in frozen DDM/CHS detergent micelle solution determined by DNP-enhanced MAS SSNMR

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] K1 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
2	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] K1 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
3	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] R2S7 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
4	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] R2S7 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
5	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] P3 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
6	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] P3 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
7	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] P4 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
8	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] P4 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
9	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] G5F6 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
10	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] G5F6 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
11	2D 13C-13C DQ-SQ	300 uM [U-13C; U-15N] S7P9 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400
12	2D 15N-13C TEDOR	300 uM [U-13C; U-15N] S7P9 Des-Arg10-Kallidin (DAKD), 10 mM not labeled AMUPOL, 50 mM not labeled HEPES, 150 mM not labeled NaCl, 4 % w/v not labeled DDM, 0.4 % w/v not labeled CHS	10% H2O/ 40%D2O/ 50% d8-glycerol	175 mM	7.6	1 atm	110	Bruker AVANCE II 400

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	400

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	500
Conformers Submitted Total Number	10
Representative Model	9 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
6	chemical shift assignment	TopSpin		Bruker Biospin
3	collection	TopSpin		Bruker Biospin
5	processing	TopSpin		Bruker Biospin
4	data analysis	TALOS+		Shen, Delaglio, Cornilescu, Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.